Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · Real-Time Price · USD

2.260

-0.090 (-3.83%)

At close: Jun 10, 2026, 4:00 PM EDT

2.270

+0.010 (0.44%)

After-hours: Jun 10, 2026, 6:20 PM EDT

Nautilus Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.63	12.39	27.65	19.4	114.52	185.62
Short-Term Investments	81.24	91.02	102.25	154.02	69.95	160.11
Cash & Short-Term Investments	95.87	103.41	129.89	173.42	184.47	345.73
Cash Growth	-30.94%	-20.39%	-25.10%	-5.99%	-46.64%	350.51%
Other Current Assets	2.96	2.56	2.93	3.42	2.74	3.49
Total Current Assets	98.83	105.96	132.83	176.84	187.21	349.22
Net Property, Plant & Equipment	30.27	31.23	32.33	36.9	32.57	31.86
Long-Term Investments	47.51	52.74	76.41	90.65	129.17	16.37
Other Long-Term Assets	1.18	1.18	1.18	1.18	1.11	1
Total Assets	177.78	191.11	242.74	305.57	350.05	398.45
Accounts Payable	1.19	0.94	0.99	1.64	1.27	1.72
Accrued Expenses	3.31	3.18	2.55	3.95	3.53	3.12
Current Portion of Leases	3.85	3.83	4.1	3.54	1.99	0.97
Total Current Liabilities	8.34	7.95	7.63	9.12	6.79	5.81
Long-Term Leases	25.02	26.19	26.38	31.09	28.34	29.06
Total Long-Term Liabilities	25.02	26.19	26.38	31.09	28.34	29.06
Total Liabilities	33.36	34.14	34.01	40.21	35.13	34.87
Common Stock	-	-	0.01	0.01	0.01	0.01
Additional Paid-in Capital	491.21	488.74	481.68	467.83	455.33	444.39
Accumulated Other Comprehensive Income	-0.09	0.24	0.06	-0.26	-1.85	-0.18
Retained Earnings	-346.72	-332.02	-273.02	-202.24	-138.56	-80.64
Total Common Shareholders' Equity	144.4	156.96	208.73	265.35	314.92	363.58
Shareholders' Equity	144.42	156.97	208.73	265.35	314.92	363.58
Total Liabilities & Equity	177.78	191.11	242.74	305.57	350.05	398.45
Total Debt	28.87	30.02	30.48	34.63	30.33	30.03
Net Cash (Debt)	67	73.39	99.42	138.79	154.14	315.7
Net Cash Growth	-8.71%	-26.18%	-28.37%	-9.96%	-51.17%	338.67%
Net Cash Per Share	0.53	0.58	0.79	1.11	1.24	3.74
Book Value	144.4	156.96	208.73	265.35	314.92	363.58
Book Value Per Share	1.14	1.24	1.66	2.12	2.53	4.30
Tangible Book Value	144.4	156.96	208.73	265.35	314.92	363.58
Tangible Book Value Per Share	1.14	1.24	1.66	2.12	2.53	4.30

SEC Filings: 10-K · 10-Q